Literature DB >> 6864676

Observer differences in detecting erosions in radiographs of rheumatoid arthritis. A comparison of posteroanterior, Nørgaard and Brewerton views.

A A Mewa, M Pui, W P Cockshott, W W Buchanan.   

Abstract

This study shows no significant advantage of Brewerton or Nørgaard radiographs in detection of erosions at metacarpophalangeal joints in patients with polyarthritis over the conventional posteroanterior view. The observer agreement for detection of exact number of erosions/pair of hands is uniformly low. Therefore, erosion index cannot be reliably used in epidemiologic surveys or therapeutic trials as an outcome measure unless steps are taken to improve the observer agreement.

Entities:  

Mesh:

Year:  1983        PMID: 6864676

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

Review 1.  An overview of commonly used radiographic scoring methods in rheumatoid arthritis clinical trials.

Authors:  Vinod Ravindran; Satish Rachapalli
Journal:  Clin Rheumatol       Date:  2010-08-21       Impact factor: 2.980

2.  Dr. Douglas Taylor and half a century of musculoskeletal Kelvinism.

Authors:  N Bellamy; W W Buchanan
Journal:  Clin Rheumatol       Date:  1988-06       Impact factor: 2.980

3.  Prediction of radiographic damage in hands and feet in rheumatoid arthritis by clinical evaluation.

Authors:  M J Plant; J Saklatvala; P W Jones; P T Dawes
Journal:  Clin Rheumatol       Date:  1994-09       Impact factor: 2.980

Review 4.  Radiographic scoring methods as outcome measures in rheumatoid arthritis: properties and advantages.

Authors:  S Boini; F Guillemin
Journal:  Ann Rheum Dis       Date:  2001-09       Impact factor: 19.103

5.  Internet hand x-rays: A comparison of joint space narrowing and erosion scores (Sharp/Genant) of plain versus digitized x-rays in rheumatoid arthritis patients.

Authors:  Hector O Arbillaga; Gregory P Montgomery; Luis P Cabarrus; Margaret M Watson; Liam Martin; Steven M Edworthy
Journal:  BMC Musculoskelet Disord       Date:  2002-04-30       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.